{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:45:15Z","timestamp":1792500315508,"version":"4.5.0"},"reference-count":113,"publisher":"Informa UK Limited","issue":"23","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biomolecular Structure and Dynamics"],"published-print":{"date-parts":[[2023,12,29]]},"DOI":"10.1080\/07391102.2023.2193985","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T11:10:11Z","timestamp":1680001811000},"page":"14582-14598","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":17,"title":["An overview of mechanism and chemical inhibitors of shikimate kinase"],"prefix":"10.1080","volume":"41","author":[{"given":"Bharath Kumar","family":"Chagaleti","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM IST Kattankulathur, Kancheepuram, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. B. Rahul","family":"Reddy","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM IST Kattankulathur, Kancheepuram, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesan","family":"Saravanan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM IST Kattankulathur, Kancheepuram, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanthakumar","family":"B.","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM IST Kattankulathur, Kancheepuram, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"D.","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM IST Kattankulathur, Kancheepuram, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Senthil Kumar","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. K.","family":"Kathiravan","sequence":"additional","affiliation":[{"name":"209, Dr. APJ Abdul Kalam Research Lab, Dept of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM IST Kattankulathur, Kancheepuram, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.05.220"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03486-14"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.2210\/pdb1VIA\/pdb"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201200428"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.3109\/10409239009090615"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm0602662"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja405853p"},{"key":"e_1_3_3_9_1","unstructured":"Brief history of tuberculosis. (2020). https:\/\/www.cdc.gov\/tb\/worldtbday\/history.htm"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01503-18"},{"issue":"1","key":"e_1_3_3_11_1","first-page":"30","article-title":"Progress towards millennium development goals for TB control in seven Asian countries","volume":"56","author":"Chadha V. K.","year":"2009","unstructured":"Chadha, V. K. (2009). Progress towards millennium development goals for TB control in seven Asian countries. The Indian Journal of Tuberculosis, 56(1), 30\u201343. https:\/\/pubmed.ncbi.nlm.nih.gov\/19402270\/","journal-title":"The Indian Journal of Tuberculosis,"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/136.3.570"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201708133"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/JB.187.23.8156-8163.2005"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033481"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/prot.24841"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/slct.201701377"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-011-1087-8"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.14060"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm201608g"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2004.08.005"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1107\/S1744309106046823"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(95)90668-1"},{"issue":"10","key":"e_1_3_3_25_1","first-page":"S231","article-title":"Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications","volume":"3","author":"Fox W.","year":"1999","unstructured":"Fox, W., Ellard, G. A., & Mitchison, D. A. (1999). Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications. The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union against Tuberculosis and Lung Disease, 3(10), S231\u2013S279. https:\/\/pubmed.ncbi.nlm.nih.gov\/10529902\/","journal-title":"The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union against Tuberculosis and Lung Disease,"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s\/10822-022-00495-w"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi0606290"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568026615666150825142527"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.4137\/PMC.S13212"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00611a004"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.794"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2836(02)00339-X"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2006.09.001"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1105\/tpc.7.7.907"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1128\/JB.181.23.7161-7167.1999"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032142"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1167498"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.56.580"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199309093291108"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.1999.01310.x"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.2210\/pdb2PT5\/pdb"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S274386"},{"issue":"17","key":"e_1_3_3_43_1","first-page":"7056","article-title":"Target validation of shikimate kinase inhibitors: A structural and kinetic perspective","volume":"57","author":"Kaczmarek A.","year":"2014","unstructured":"Kaczmarek, A. (2014). Target validation of shikimate kinase inhibitors: A structural and kinetic perspective. Journal of Medicinal Chemistry, 57(17), 7056\u20137071.","journal-title":"Journal of Medicinal Chemistry,"},{"issue":"17","key":"e_1_3_3_44_1","first-page":"5306","article-title":"Structure-based target validation using shikimate kinase inhibitors","volume":"23","author":"Kailasam P.","year":"2015","unstructured":"Kailasam, P., & Holliday, G. L. (2015). Structure-based target validation using shikimate kinase inhibitors. Bioorganic & Medicinal Chemistry, 23(17), 5306\u20135317.","journal-title":"Bioorganic & Medicinal Chemistry,"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm5003606"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1021\/jp972501l"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a017916"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2008.96"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/0041-3879(91)90017-m"},{"issue":"4","key":"e_1_3_3_50_1","first-page":"481","article-title":"Target validation of shikimate kinases","volume":"16","author":"Kolb A.","year":"2012","unstructured":"Kolb, A., & Schirmer, T. (2012). Target validation of shikimate kinases. Current Opinion in Chemical Biology, 16(4), 481\u2013491.","journal-title":"Current Opinion in Chemical Biology,"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1110\/ps.52501"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.201600019"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0285.2010.01005.x"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.2174\/157340609787582882"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01476-12"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.6.2294-2301.2005"},{"key":"e_1_3_3_57_1","volume-title":"Harrison\u2019s principles of internal medicine","author":"Longo D. L.","year":"2012","unstructured":"Longo, D. L., Fauci, A. S., Hauser, S. L., & Jameson, J. L. (2012). Harrison\u2019s principles of internal medicine (18th ed.). McGraw Hill. 165: Tuberculosis. https:\/\/books.google.co.in\/books?id=RSLZvLBjjF4C&pg=PT141&lpg=PT141&dq=L.+Fauci.+Harrison%27s+Principles+of+Internal+Medicine+(18th+ed.).+New+York:+McGraw+Hill.+pp.+Chapter+165:+Tuberculosis+(2012).&source=bl&ots=ONg0FyjHKx&sig=ACfU3U3C5caH01HMcvRmmsE8Mmd5dypepQ&hl=en&sa=X&ved=2ahUKEwiz3a7B6OX2AhVezzgGHcFcA6cQ6AF6BAgZEAM.","edition":"18"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201303575"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1171583"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00778-15"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1258\/0956462053057576"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.6b00056"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M300794200"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161282027140630122724"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2370427"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.2210\/pdb3VAA\/pdb"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00044-013-0803-1"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules190913161"},{"key":"e_1_3_3_70_1","unstructured":"New Drug Therapy Approvals. (2019). US Food and Drug Administration . https:\/\/www.fda.gov\/drugs\/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products\/new-drug-therapy-approvals-2019"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25061259"},{"key":"e_1_3_3_72_1","first-page":"19e","volume-title":"Harrison\u2019s principles of internal medicine","author":"O\u2019Donnell M. R.","year":"2014","unstructured":"O\u2019Donnell, M. R., Reddy, D., & Saukkonen, J. J. (2014). Antimycobacterial agents. In D. Kasper, A. Fauci, S. Hauser, D. Longo, J. Jameson, & J. Loscalzo (Eds.), Harrison\u2019s principles of internal medicine, 19e. McGraw Hill. https:\/\/accessmedicine.mhmedical.com\/content.aspx?bookid=1130&sectionid=79737263"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02439-17"},{"issue":"10","key":"e_1_3_3_74_1","first-page":"925","article-title":"Shikimate kinase target validation: Applications to drug Pedro discovery","volume":"8","author":"O\u2019Neill D. A.","year":"2008","unstructured":"O\u2019Neill, D. A. (2008). Shikimate kinase target validation: Applications to drug Pedro discovery. Current Topics in Medicinal Chemistry, 8(10), 925\u2013937.","journal-title":"Current Topics in Medicinal Chemistry,"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.3390\/biophysica1030025"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1086\/338784"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.22541\/au.160491622.24853329\/v1"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(09)70330-5"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1107\/S090744490402517X"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1039\/C9QO00562E"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.5b00324"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.9b00204"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-015-7268-8"},{"key":"e_1_3_3_84_1","volume-title":"36 million people with TB cured","author":"Ramakant B.","year":"2009","unstructured":"Ramakant, B. (2009). 36 million people with TB cured. World Health Organization. http:\/\/www.weeklyblitz.net\/363"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.104083"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060933"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26216736"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26216736"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1086\/338004"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573409915666191025112150"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01191-19"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm500571f"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.8b00231"},{"key":"e_1_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2013.12.004"},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b00415"},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063128"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1038\/35016103"},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1901346116"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2013.9"},{"key":"e_1_3_3_100_1","volume-title":"Oral Presentation at: Antimicrobial Drugs Advisory Committee","year":"2019","unstructured":"TB Alliance. (2019, June 6). Pretomanid and BPaL regimen for treatment of highly resistant tuberculosis [Paper presentation]. Oral Presentation at: Antimicrobial Drugs Advisory Committee, Silver Spring, MD. https:\/\/www.fda.gov\/media\/128001\/download"},{"key":"e_1_3_3_101_1","unstructured":"TB Alliance. (2022). https:\/\/www.Tballiance.org\/portfolio"},{"key":"e_1_3_3_102_1","unstructured":"TB Database. (2021). http:\/\/Tbdb.bu.edu\/cgi-bin\/GeneDetails.html?id=SRv2539c"},{"key":"e_1_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00240-19"},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijtb.2020.10.001"},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm051197e"},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14414"},{"key":"e_1_3_3_107_1","unstructured":"UniProt Database. (2021). https:\/\/www.uniprot.org\/uniprot\/P9WPY3#function"},{"key":"e_1_3_3_108_1","unstructured":"US Food and Drug Administration. (2022). Drug approvals and databases . https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/drug-approvals-and-databases"},{"key":"e_1_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30426-0"},{"key":"e_1_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094462"},{"key":"e_1_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1038\/194205a0"},{"key":"e_1_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.000095"},{"key":"e_1_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02155-18"},{"key":"e_1_3_3_115_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.200501"},{"key":"e_1_3_3_116_1","volume-title":"2018 WGND Annual Meeting","author":"Young Lag C.","year":"2018","unstructured":"Young Lag, C. (2018). Delpazolid (LCB01-0371), Oxazolidinone antibiotic for MDR-TB LegoChem Biosciences. In 2018 WGND Annual Meeting. https:\/\/www.newTbdrugs.org\/sites\/default\/files\/meetings\/files\/07_WGND%20presentation-Lego-Chem%20Bio.pdf"},{"key":"e_1_3_3_117_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00165-18"}],"container-title":["Journal of Biomolecular Structure and Dynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/07391102.2023.2193985","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T09:58:33Z","timestamp":1702288713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/07391102.2023.2193985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":113,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2023,12,29]]}},"alternative-id":["10.1080\/07391102.2023.2193985"],"URL":"https:\/\/doi.org\/10.1080\/07391102.2023.2193985","relation":{},"ISSN":["0739-1102","1538-0254"],"issn-type":[{"value":"0739-1102","type":"print"},{"value":"1538-0254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=tbsd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=tbsd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-09-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}